Modification of the lymphocyte response to mitogens by cyclic AMP and GMP.
D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects; D003994:Bucladesine / Q000378:metabolism / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D003208:Concanavalin A / Q000494:pharmacology; D003470:Culture Media; D006152:Cyclic GMP / Q000378:metabolism / Q000494:pharmacology*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004731:Endotoxins / Q000494:pharmacology; D004926:Escherichia coli / Q000276:immunology; D037102:Lectins / Q000494:pharmacology; D007930:Leucine / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008934:Mitogens / Q000494:pharmacology*; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D013154:Spleen / Q000166:cytology; D013268:Stimulation, Chemical; D013601:T-Lymphocytes / Q000187:drug effects; D013806:Theophylline / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D003470:Culture Media; D004731:Endotoxins; D037102:Lectins; D008934:Mitogens; D014316:Tritium; D003208:Concanavalin A; D012313:RNA; D003994:Bucladesine; D013806:Theophylline; D007930:Leucine; D006152:Cyclic GMP; D013936:Thymidine; D014529:Uridine